SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

Salix latest purchase by Valeant after Dendreon deal

26-Feb-2015 - Valeant has signed a $14.5bn deal to acquire GI drugmaker Salix days after agreeing to purchase Provenge-maker Dendreon.

Shire steps further into rare diseases with $70m acquisition

25-Feb-2015 - Shire has acquired privately-held Meritage for an upfront fee of $70m and additional contingent payments based on the achievement of development and regulatory milestones. 

Drug delivery tech’s shares skyrocket as it helps Novo Nordisk clear Phase II hurdle

23-Feb-2015 - A potential Type 2 diabetes drug from Novo Nordisk has met the primary endpoint of a Phase II trial and shares of Emisphere Technology, which helped to formulate the oral version of semaglutide, jumped by as much as 70% on Friday.

Fresenius Kabi sells cancer compounding biz to NewCo Pharma

17-Feb-2015 - Fresenius Kabi has sold its cancer drug pharmacy network CFL GmbH to NewCo Pharma GmbH five years after spending €42m to buy compounding capacity in Germany.

Suboxone sales down as opioid addiction drug market intensifies

12-Feb-2015 - Opioid addiction drug Suboxone lost market share in 2014 according to newly independent Indivior, whose management says it is not intimidated by increased competition.

Ex-Unigene execs who run Enteris add API contracting service to delivery tech licensing business

12-Feb-2015 - Enteris BioPharma has broadened its business beyond drug delivery tech licensing and launched a contract API manufacturing service.

One in the eye for Lucentis? Pfenex says Pfizer takeover will benefit Hospira pact

11-Feb-2015 - Pfenex expects its new Lucentis biosimilar partnership to benefit from Pfizer’s economic clout after the Hospira takeover completes.

Chinese researchers develop nanocarrier for pancreatic cancer drug

09-Feb-2015 - Researchers from the Oncology Department of Tianjin Medical University Cancer Hospital in China recently published a study in Advanced Functional Materials  announcing the creation of a new nano-carrier for pancreatic cancer treatments.

breaking news

Third time's a charm: Pfizer to buy Hospira for $17bn

05-Feb-2015 - Pfizer has entered into a definitive merger agreement to buy Hospira for $17bn.

Inhaled insulin: Sanofi alone as Big Pharma declines to revisit past

04-Feb-2015 - Pfizer, Lilly and Novo Nordisk will not be revisiting inhaled insulin opportunities despite the US launch and expected success of Sanofi and MannKind’s Afrezza.

INFOGRAPHIC

Ebola: which are the leading vaccine candidates?

27-Jan-2015 - BioPharma-Reporter.com's interactive guide to the world's most promising Ebola vaccines.

Halal and Kosher stamps of approval for pregnancy drug

26-Jan-2015 - A morning sickness drug made by Duchesnay USA will now display Halal and Kosher symbols – a move the company said is the first case of Kosher certification for an oral prescription drug in the US.

EMA expands generic assessment pilot globally in response to industry

21-Jan-2015 - The EMA has responded to feedback from generic drugmakers by broadening an assessment sharing pilot to regulators outside the EU.

Novozymes predicts half-life boost for pharma business, but lets long term rev forecast slide on oil prices

20-Jan-2015 - Novozymes finished 2014 with higher pharma revenues thanks in part to GSK's adoption of its albumin half-life extension technology, Veltis.

MannKind: Small step for delivery tech R&D after Afrezza's giant leap

19-Jan-2015 - MannKind’s development of new drugs with the delivery technology used in its inhalable insulin drug Afrezza will progress without founder Alfred Mann at the helm.

Capsugel buys ionic liquid tech IP to enhance lipid-based drug solubility

12-Jan-2015 - Capsugel has acquired a technology platform which uses ionic liquids to enhance the solubility of lipid-based drug delivery systems.

US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments

06-Jan-2015 - Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of the new class of treatments for America’s three million Hepatitis C sufferers.

Rouble trouble: Big Pharma exposure to Russian currency volatility limited

17-Dec-2014 - Big Pharma firms’ exposure to Russia’s volatile rouble is limited and planned manufacturing investments will go ahead according to observers.

In nano-rod we trust: magnetic pulse tech breakthrough for cancer drug delivery

17-Dec-2014 - A magnetic pulse technology that can align and push nanoparticles to points distant to magnet surfaces could finally make magnets attractive for deep tissue drug delivery according to researchers.

Sosei looks to $23bn peptide market with acquisition of tech firm Jitsubo

15-Dec-2014 - Sosei Group Corporation is looking to peptides to replenish its pipeline through the $70m acquisition of technology firm Jitsubo.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...

Product Innovation